GlassScriptPhysician profile
Lacey Matheis
NPI 1205235165
$139,335.51
in general payments reported to CMS, 2019-2025
5 companies · $44K in 2025
The $44K reported for 2025 was more than what 99% of Family providers received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $13K · 2022: $15K · 2023: $27K · 2024: $40K · 2025: $44K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $76K · Travel and Lodging: $28K · Food and Beverage: $5,211 · Consulting Fee: $1,898.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $75,858.01 |
| Travel and Lodging | $28,206.88 |
| Food and Beverage | $5,211.19 |
| Consulting Fee | $1,898.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Acadia Pharmaceuticals INC | $97,354.97 | 2021-2025 | Nuplazid |
| Mylan Specialty L.P. | $23,907.87 | 2022-2024 | Yupelri, Yupelri |
| Viatris Specialty LLC | $17,760.07 | 2025 | Yupelri |
| Urovant Sciences INC | $188.44 | 2022 | |
| Biohaven Pharmaceuticals, INC. | $124.16 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lacey Matheis listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.